Acadia Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
Acadia Pharmaceuticals USD 26.67M 7.68M 2025-06
ALKERMES USD 87.1M 64.63M 2025-06
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Corcept Therapeutics USD 35.15M 14.6M 2025-06
Cytokinetics USD -134370000 27.01M 2025-06
Eisai JPY 14.47B 13.52B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Incyte USD 405M 246.8M 2025-06
J&J USD 5.54B 5.46B 2025-06
Moderna USD -825000000 146M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Pfizer USD 2.91B 58M 2025-06
Prothena USD -57956000 1.04M 2024-12
PTC Therapeutics USD -64849000 931.41M 2025-06
Sarepta Therapeutics USD 196.89M 644.4M 2025-06
Ultragenyx Pharmaceutical USD -114951000 36.13M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06


Acadia Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.